TriFoil Imaging
TriFoil Imaging designs and manufactures preclinical small-animal molecular imaging systems — most notably the InSyTe FLECT/CT dual-modality platform — and sells them with applications support and service to pharmaceutical, biotech, and academic research customers worldwide.
- Company typePrivate
- Founded2013
- HeadquartersChatsworth, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What TriFoil Imaging does
TriFoil Imaging is a US-based developer and manufacturer of preclinical small-animal molecular imaging systems, formed in 2013 through the merger of Gamma Medica and Bioscan. The company's flagship product is the InSyTe FLECT/CT, a dual-modality platform that combines proprietary Fluorescence Emission Computed Tomography (FLECT) with inline X-ray CT to deliver true 360° 3D tomographic imaging in a single fused scan. The FLECT subsystem uses 4 NIR lasers (642 nm, 705 nm, 730 nm, 780 nm) and a ring of 48 photodiode detectors on a rotating gantry to acquire full-angle optical fluorescence data from small animals, which is computationally reconstructed into volumetric images for in vivo molecular imaging. The company also sells the InSyTe CT as a standalone preclinical CT system that is upgradeable to the full FLECT/CT configuration.
TriFoil generates revenue primarily through capital equipment sales of the InSyTe platform to pharmaceutical companies, biotechnology firms, and academic research institutions, supplemented by recurring service, calibration, and applications support contracts — including paid maintenance for legacy instruments acquired through the Gamma Medica, Bioscan, and GE Healthcare mergers. The company pursues a dual go-to-market motion combining direct enterprise field sales (with applications scientist support from lab setup through image analysis) and a global authorized distributor network spanning approximately 30+ countries across North America, Europe, the Middle East, Africa, Asia Pacific, and the CIS. The company maintains a formal research collaboration with Johns Hopkins University's Division of Cancer Imaging Research to validate preclinical cancer imaging applications. TriFoil Imaging LLC is privately held, headquartered in Cheyenne, Wyoming with operations in Chatsworth, California, and operates with an 11–50 person team. No outside funding rounds or revenue figures have been publicly disclosed.
TriFoil Imaging firmographics
Firmographics- Name
- TriFoil Imaging
- Legal name
- TriFoil Imaging LLC
- Website
- https://trifoilimaging.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- TriFoil Imaging designs and manufactures preclinical small-animal molecular imaging systems — most notably the InSyTe FLECT/CT dual-modality platform — and sells them with applications support and service to pharmaceutical, biotech, and academic research customers worldwide.
- Ownership category
- akta.pro rank
Where TriFoil Imaging is headquartered
LocationHeadquarters
- HQ city
- Chatsworth
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
TriFoil Imaging business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Preclinical Imaging Hardware Systems: Sale of InSyTe FLECT/CT and InSyTe CT preclinical imaging systems to pharmaceutical companies, biotech firms, and academic research institutions.
- Service and Support: Global network of Field Service Engineers providing installation, preventative maintenance, calibration, technical guidance, and emergency repair services. Also supports legacy scanners from Bioscan, Gamma Medica, and GE Healthcare.
- Applications Support: Applications Scientists assist customers from setting up preclinical labs to designing application protocols to post-processing and image analysis.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise/Custom Pricing |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
TriFoil Imaging product offering
Product offeringCore offering
TriFoil Imaging designs, manufactures, and supports preclinical molecular imaging systems, primarily the InSyTe FLECT/CT platform that combines 360° fluorescence tomography (FLECT) with inline X-ray CT for small animal in vivo imaging. The company also offers the InSyTe CT standalone preclinical CT system and provides global service and applications support for its current products and legacy instruments acquired through mergers with Gamma Medica and Bioscan.
Product overview
TriFoil Imaging offers a portfolio of preclinical molecular imaging products centered on its proprietary FLECT (FLuorescence Emission Computed Tomography) technology. The core current product line consists of two main systems: the InSyTe FLECT/CT (dual-modality platform combining 360° fluorescence tomography with X-ray CT) and InSyTe CT (standalone preclinical CT system). Both systems are designed for small animal in vivo imaging using near-infrared fluorescence. The company also maintains an extensive portfolio of legacy preclinical imaging systems acquired through mergers with Gamma Medica and Bioscan, including Triumph, eXplore, LOCUS, FLEX, A-SPECT, LabPET, XO, and XSPECT platforms. TriFoil Imaging provides global service and applications support for all its products and legacy instruments.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Full 360° in vivo acquisition of fluorescence emission (vs. limited angle approaches by competitors)
- +1 more outcomes
Companies that use TriFoil Imaging
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
TriFoil Imaging technology and API
TechnologyAPI detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability2 records
Feature4 records
TriFoil Imaging partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core.
- Johns Hopkins UniversitycoreApplication partnership with the Division of Cancer Imaging Research at Johns Hopkins University. Under the direction of Dr. Zaver Bhujwalla, researchers use TriFoil's InSyTe FLECT/CT system to develop sophisticated pre-clinical models for cancer research and treatment using 360° 3D fluorescence imaging capability.
- AllEightscoreOfficial distributor for Singapore and Malaysia markets.
- ATG ScientificcoreOfficial distributor for UK and Ireland markets.
- AXT Pty LtdcoreOfficial distributor for Australia and New Zealand markets.
- BioOnecoreOfficial distributor for China market.
- Crisel InstrumentscoreOfficial distributor for Italy market.
- Emphor FZCOcoreOfficial distributor for Bahrain, Kuwait, Oman, Qatar, and UAE markets.
- Fusion Scientific TechnologiescoreOfficial distributor for India market.
- GenMedica SAcoreOfficial distributor for Armenia, Azerbaijan, Belarus, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Moldova, Russia, Tajikistan, Turkmenistan, Ukraine, and Uzbekistan.
- IMTEcoreOfficial distributor for Turkey market.
- JC GeneticscoreOfficial distributor for Canada market.
- Lavi LtdcoreOfficial distributor for Israel market.
- OncoMed SolutionscoreOfficial distributor for Germany, Netherlands, Belgium, Switzerland, Austria, Hungary, and Luxembourg markets.
- Science Imaging Scandinavia ABcoreOfficial distributor for Scandinavian markets.
- Shimadzu Scientific KoreacoreOfficial distributor for South Korea market.
Scale indicators3 records
Recent moves6 records
Expansion highlights5 records
TriFoil Imaging competitors and assessment
Company assessmentDirect peers
- MILabs:
- Spectral Instruments Imaging: Spectral Instruments Imaging produces preclinical optical imaging systems (Ami, Lago) for NIR and bioluminescence imaging in small animals, directly competing with TriFoil's fluorescence tomography platform for the same research customer base.
- LI-COR Biosciences: LI-COR's Pearl NIR small animal imaging system is a direct competitor in NIR fluorescence preclinical imaging. Both companies target the same use cases (NIR fluorescence in vivo imaging in mice) and sell to overlapping academic and pharma research customers.
- Mediso Medical Imaging Systems: Mediso manufactures preclinical PET, SPECT, and CT imaging systems (nanoScan, AnyScan) that compete directly with TriFoil's molecular imaging portfolio, particularly the legacy SPECT/CT product lines inherited from Gamma Medica.
- Aspect Imaging: Aspect Imaging produces compact preclinical MRI systems and M-Power software, serving similar preclinical research markets with anatomical imaging capabilities that overlap with TriFoil's preclinical CT portfolio.
- MR Solutions: MR Solutions manufactures preclinical cryogen-free MRI, PET, SPECT, and CT imaging systems for research applications, competing in the same multimodal preclinical imaging category as TriFoil.
Broad incumbents
- Bruker BioSpin: Bruker offers preclinical MRI, PET, SPECT, and optical imaging systems (including the Xtreme and SkyScan products) used by the same pharma/biotech and academic preclinical research customers as TriFoil, with overlapping multimodal molecular imaging positioning.
- Revvity (formerly PerkinElmer Life Sciences): Revvity's IVIS optical imaging platform is the most widely used in vivo optical imaging system for preclinical research, directly competing with TriFoil's FLECT technology. Both companies serve pharma, biotech, and academic researchers needing fluorescence-based molecular imaging.
- GE Healthcare: GE Healthcare is the original manufacturer of several legacy preclinical imaging products (Triumph, Locus, eXplore CT120) that TriFoil now services. As a broad incumbent, GE retains a presence in adjacent preclinical and clinical imaging markets and represents a reference point for the legacy product category.
Market position
Strengths1 record
Weaknesses1 record
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
TriFoil Imaging social profiles
Digital presenceTriFoil Imaging financial estimates
Financial estimateRevenue estimate
Valuation estimate
TriFoil Imaging leadership team
Management profileNumber of profiles
Profiles6 records
TriFoil Imaging funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
TriFoil Imaging M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about TriFoil Imaging
What does TriFoil Imaging do?
TriFoil Imaging designs, manufactures, and supports preclinical molecular imaging systems, primarily the InSyTe FLECT/CT platform that combines 360° fluorescence tomography (FLECT) with inline X-ray CT for small animal in vivo imaging. The company also offers the InSyTe CT standalone preclinical CT system and provides global service and applications support for its current products and legacy instruments acquired through mergers with Gamma Medica and Bioscan.
Is TriFoil Imaging a public or private company?
TriFoil Imaging is a private company. It is currently operating.
When was TriFoil Imaging founded?
TriFoil Imaging was founded in 2013. It employs 11 to 50 people.
Where is TriFoil Imaging based?
TriFoil Imaging is headquartered in Chatsworth, United States, in the North America region.
How does TriFoil Imaging make money?
Three revenue lines are on record. Preclinical Imaging Hardware Systems are the primary driver. The others are service and Support and applications Support.
Who are TriFoil Imaging's main competitors?
Direct peers on record are MILabs, Spectral Instruments Imaging, LI-COR Biosciences, Mediso Medical Imaging Systems, Aspect Imaging and MR Solutions. Broad incumbents are Bruker BioSpin, Revvity (formerly PerkinElmer Life Sciences) and GE Healthcare.
Does TriFoil Imaging have an API?
No public API is recorded for TriFoil Imaging.